Comments
Loading...
Grifols (NASDAQ:GRFS) Stock Quotes, Forecast and News Summary
Grifols Stock (NASDAQ: GRFS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Grifols (GRFS) stock?
You can purchase shares of Grifols (NASDAQ:GRFS) through any online brokerage.
Who are Grifols (GRFS) competitors?
Other companies in Grifols’s space includes: Legend Biotech (NASDAQ:LEGN), Avidity Biosciences (NASDAQ:RNA), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS) and Ionis Pharmaceuticals (NASDAQ:IONS).
What is the forecast, or price target, for Grifols (GRFS) stock?
Grifols has a consensus price target of $10.50.
What is the current price for Grifols (GRFS)?
The stock price for Grifols (NASDAQ: GRFS) is $8.41 last updated November 21, 2024 at 9:29 AM EST.
Does Grifols (GRFS) pay a dividend?
A quarterly cash dividend of 0.34 per share of Class A Common Stock. The quarterly cash dividend was payable on June 14, 2021 to stockholders of record on June 3, 2021.
When is Grifols (NASDAQ:GRFS) reporting earnings?
Grifols’s Q2 earnings are confirmed for Thursday, July 28, 2022.
Is Grifols (GRFS) going to split?
There is no upcoming split for Grifols.
What sector and industry does Grifols (GRFS) operate in?
Grifols is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.